Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
Jose D. Herazo‐Maya(University of South Florida), Naftali Kaminski(Yale University), Imre Noth(University of Chicago), Julian A. Villalba(Brigham and Women's Hospital), Melinda Klesen(University of Pittsburgh), Argyrios Tzouvelekis(Yale University), Erica L. Herzog(Yale University), Antje Prasse(University Medical Center Freiburg), George Michel(Yale University), Kathleen O. Lindell(University of Pittsburgh), Iván O. Rosas(University of Pittsburgh), Heather Lynn(Yale University), Brenda Juan-Guardela(Yale University), Joe G. N. Garcia(Johns Hopkins University), Nachelle Aurelien(Yale University), Miriam F. Moffatt(Imperial College London), Kevin F. Gibson(University of Pittsburgh), Toby M. Maher(Imperial College London), Philip L. Molyneaux(Guy's and St Thomas' NHS Foundation Trust), Ziv Bar‐Joseph(Carnegie Mellon University), Juan C. Osorio(Memorial Sloan Kettering Cancer Center), Hongyu Zhao(Yale University), Cristobal Risquez(Imperial College London), Xiting Yan(Yale University), Qin Li(Yale University), William Cookson(Imperial College London), Yingze Zhang(Hebei Medical University), Jiehuan Sun(Yale University)
Cited by 191
Related Papers
Sarcoidosis
|The Lancet|2013|1.1k
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands
|Nature Genetics|2017|927
Plasticity of marrow-derived stem cells
|Blood|2003|830